Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

University of Helsinki, Hospital de Clínicas de Porto Alegre, Mexican Social Security Institute, University of New Mexico, National Taiwan University Hospital, Sexual Health Clinic, Väestöliitto, Manchester Academic Health Science Centre, St Mary's Hospital, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Universidade Estadual de Campinas (UNICAMP), The Kids Research Institute Australia, Ohio Pediatric Research Association, Chulalongkorn University, Philippine General Hospital, Makati Medical Center, Royal Women's Hospital, University of Melbourne, Queen Mary University of London, Cancer Research UK, University of Alberta, University of Manitoba, Stiftung Juliusspital, KU Leuven, University of York, Hull York Medical School, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Belgium), Tampere University, Tampere University, GlaxoSmithKline (United States)